http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b47e94838d17198b965727135d217c62
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Vose M. Vose |
| name | Julie M. Vose Julie M Vose |
| given-name | Julie Julie M Julie M. |
| organization-name | 2Internal Medicine-Oncology/Hematology Section, and Division of Hematology and Oncology University of Nebraska Medical Center Omaha NE USA From the Leukemia/Lymphoma Molecular Profiling Project, Departments of Pathology and Microbiology, Genetics, Internal Medicine, and Preventive and Societal Medicine, University of Nebraska Medical Center, Omaha, NE; Metabolism Branch and Laboratory of Pathology, Center for Cancer Research, and Biometrics Research Branch, Department of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD; Department of Pathology, University of Arizona, Tucson, AZ;... Division of Hematology/Oncology, University of Nebraska Medical Center, Omaha, NE, USA From the University of Michigan Medical Center, Ann Arbor, MI; Memorial Sloan-Kettering Cancer Center and Cornell University Medical College, New York, NY; University of Washington Medical Center and Corixa Corporation, Seattle, WA; University of Alabama, Birmingham, AL; Kaiser Northern California, Vallejo; Stanford University Medical Center, Stanford, CA; University of Nebraska Medical Center, Omaha, NE; and St Bartholomew’s Hospital, London, United Kingdom. From the Departments of Internal Medicine, Anatomy and Cell Biology, Pathology and Microbiology, and Preventive and Societal Medicine, University of Nebraska Medical Center, Omaha, NE; Indiana University Medical Center, Indianapolis, IN; Queens Medical Center, Honolulu, HI; Mayo Clinic, Rochester, MN; and Rocky Mountain Cancer Center, Denver, CO. Julie M. Vose, University of Nebraska Medical Center, Omaha, NE; Shelly Carter, EMMES, Rockville; Richard Ambinder, Johns Hopkins Medical Center, Baltimore, MD; Linda J. Burns, University of Minnesota, Minneapolis, MN; Ernesto Ayala and Marcie Tomblyn, H. Lee Moffitt Cancer Center, Tampa, FL; Oliver W. Press, Fred Hutchinson Cancer Center, Seattle, WA; Craig H. Moskowitz, Memorial Sloan-Kettering Cancer Center, New York; Richard Fisher, University of Rochester, Rochester, NY; Edward A. Stadtmauer,... Division of Oncology & Hematology, University of Nebraska Medical Center, Omaha, NE, USA Division of Hematology and Oncology University of Nebraska Medical Center Omaha Nebraska USA Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska. From the Mayo Clinic, Rochester, MN; Montefiore Medical Center-North Division, and New York Medical College V, Bronx, NY; Mid-Ohio Oncology/Hematology, Columbus, OH; Mayo Clinic, Scottsdale, AZ; Gundersen Clinic, La Crosse, WI; Pacific Coast Hematology/Oncology, Fountain Valley, CA; Swedish Cancer Institute, Seattle, WA; Saskatoon Cancer Center, Saskatoon, Canada; Celgene Corporation, Summit, NJ; and the University of Nebraska, Omaha, NE. Division of Hematology/Oncology, University of Nebraska Medical Center, 600 S 42nd St, Omaha, NE 68198, USA. Division of Hematology/Oncology University of Nebraska Medical Center Omaha Nebraska Authors' Affiliations: Departments of 1Pathology and Microbiology, 2Internal Medicine, and 3Biostatistics, University of Nebraska Medical Center, Omaha, Nebraska; 4Lymphoma Group, Molecular Pathology Program, Spanish National Cancer Center, Madrid, Spain; 5Nuffield Department of Clinical Laboratory Sciences, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom; 6Department of Pathology, Rikshospitalet-Radiumhospitalet Medical Center, University of Oslo, Oslo, Norway; 7Department of Pathology, Oregon Health and Science University, Portland, Oregon; 8Metabolism Branch and 9Laboratory of Pathology, Division of Cancer Treatment and Diagnosis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland; 10Department of Pathology, British Columbia Cancer Agency, Vancouver, BC, Canada; 11Institute of Pathology, University of Würzburg, Würzburg, Germany; 12Department of Clinical Pathology, Robert-Bosch-Krankenhaus, and Institute of Clinical Pharmacology, Stuttgart, Germany; 13Departmen Department of Internal Medicine, 987680, Nebraska Medical Center, Omaha, Nebraska, 68198–7680, USA 27Fred & Pamela Buffett Cancer Center; and 13Division of Hematology and Oncology, University of Nebraska Medical Center, Omaha, Nebraska. Department of Hematology/Oncology, University of Nebraska Medical Center, Omaha, NE; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA 3Internal Medicine-Section of Oncology/Hematology, Center for Research in Leukemia and Lymphoma, University of Nebraska Medical Center, Omaha, Nebraska and Department of Internal Medicine University of Nebraska Medical Center Omaha NE USA Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE; and The University of Nebraska Medical Center, Omaha, NE Section of Hematology/Oncology, University of Nebraska Medical Center, Omaha; Hematology/Oncology, and From the University of Nebraska Medical Center, Omaha, NE Oncology/Hematology University of Nebraska Medical Center Omaha NE USA From the Department of Internal Medicine, Section of Hematology/Oncology, Department of Radiation Oncology, Department of Radiology, Section of Nuclear Medicine, and Department of Preventive and Societal Medicine, University of Nebraska Medical Center, Omaha, NE Department of Internal Medicine Division of Hematology‐Oncology, University of Nebraska Medical Center Omaha Nebraska University of Nebraska Medical Center, Omaha, NE; University of Nebraska Medical Center Omaha, NE 68198-3330 Department of Internal Medicine and Ronald Levy, Andrew J. Gentles, Chih Long Liu, Robert Tibshirani, and Ash A. Alizadeh, Stanford University Medical Center, Palo Alto; Christos E. Emmanouilides and John M. Timmerman, University of California Los Angeles Medical Center, Los Angeles; Lori A. Kunkel, Diane E. Ingolia, and Dan W. Denney Jr, Genitope, Fremont, CA; Kristen N. Ganjoo and Michael J. Robertson, Indiana University Medical Center, Indianapolis, IN; John P. Leonard, Weill Medical College of Cornell University, New York, NY; Julie M.... Division of Hematology/Oncology University of Nebraska Medical Center Omaha Nebraska 68198‐7680 Julie M. Vose, University of Nebraska Medical Center, Omaha, NE; Daniel Hayes, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI From Our Lady of Mercy Cancer Center, New York Medical College, Bronx, NY; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL; University of California, Davis Cancer Center, Sacramento; Pacific Coast Hematology/Oncology Medical Group, Fountain Valley, CA; University of Nebraska, Nebraska Medical Center, Omaha, NE; Gundersen Clinic, La Crosse, WI; BC Community Oncology Trialists, Burnaby, British Columbia, Canada; Instat Services, Chatham; Celgene Corporation, Summit, NJ; and Mayo... The Nebraska Medical Center Omaha NE USA From the Roswell Park Cancer Institute, Buffalo, NY; Biogen Idec Inc, San Diego, CA; Mayo Clinic, Rochester, MN; University of Nebraska, Omaha, NE; M.D. Anderson Cancer Center, Houston, TX; University of California Los Angeles, Los Angeles, CA; Arizona Cancer Center, Tucson, AZ; Duke University, Durham, NC; Cornell Medical Center, New York, NY; Northwestern University, Chicago, IL; and University of Colorado Health Sciences Center, Aurora, CO Andrew M. Evens, Tufts University School of Medicine, Boston; Aimee Kroll-Desrosiers, University of Massachusetts Medical School, Worcester, MA; Ranjana Advani and Stavroula Otis, Stanford University Medical Center, Stanford, CA; Oliver W. Press and Linda M. Parker, Fred Hutchinson Cancer Research Center, Seattle, WA; Izidore S. Lossos, Liat Nadav Dagan, and Jose Sandoval, University of Miami School of Medicine, Miami, FL; Julie M. Vose, University of Nebraska Medical Center, Omaha, NE; Francisco J.... Section of Hematology/Oncology, University of Nebraska Medical Center, Omaha, Nebraska University of Nebraska Medical Center, Omaha 32Fred & Pamela Buffett Cancer Center; and Genome Technology Branch, National Human Genome Research Institute, Bethesda, MD 20892; Departments of Pathology and Microbiology, Preventive and Societal Medicine, and Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198; and Institute for Genetic Medicine, University of Southern California, Los Angeles, CA 90089 3Internal Medicine-Section of Oncology/Hematology, Center for Research in Leukemia and Lymphoma, University of Nebraska Medical Center, Omaha, Nebraska From the University of Nebraska Medical Center, Omaha, NE; Rikshospitalet-Radiumhospitalet Medical Center, University of Oslo, Oslo, Norway; British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Robert-Bosch-Krankenhaus, Stuttgart; University of Würzburg, Würzburg; Charité–Universitätsmedizin Berlin, Berlin, Germany; Oregon Health and Science University, Portland, OR; University of Barcelona, Barcelona, Spain; and Division of Cancer Treatment and Diagnosis, Center for Cancer Research,... University of Nebraska Medical Center Omaha NE USA Daniel J. Landsburg and Anthony R. Mato, University of Pennsylvania; James N. Gerson and Stefan K. Barta, Temple University, Philadelphia, PA; Marissa K. Falkiewicz, Robert Wood Johnson Medical School, New Brunswick; Christina Howlett, Tatyana Feldman, and Anthony R. Mato, Hackensack University Medical Center, Hackensack, NJ; Joseph Maly and Kristie A. Blum, Ohio State University, Columbus; Brian T. Hill, Cleveland Clinic, Cleveland, OH; Shaoying Li and L. Jeffrey Medeiros, MD Anderson Cancer Center,... From the Section of Oncology-Hematology; Summer Undergraduate Research Program, Department of Internal Medicine; Department of Pathology, University of Nebraska Medical Center, Omaha, NE. University of Nebraska, Omaha; Department of Internal Medicine, Division of Hematology‐Oncology University of Nebraska Medical Center Omaha Nebraska From the Center for Lymphoma and Myeloma, Weill Cornell Medical College and New York Presbyterian Hospital, New York, NY; Mailman School of Public Health, Columbia University, New York, NY; University of Nebraska Medical Center, Omaha, NE; and the Dana-Farber Cancer Institute, Boston, MA. University of Nebraska Cancer Center, Omaha, NE From the Division of Hematology/Oncology, University of Nebraska Medical Center, Omaha, NE; Office of Hematology and Oncology Products, U.S. Food and Drug Administration, Rockville, MD; Division of Hematology/Oncology, Northwestern University Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL. Daniel F. Hayes, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; and Julie Vose, University of Nebraska Medical Center, Omaha, NE Division of Oncology and Hematology Department of Internal Medicine University of Nebraska Medical Center Omaha Nebraska USA *Departments of Pathology and Microbiology, Preventive and Societal Medicine, and Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198; Department of Internal Medicine, The Nebraska Medical Center, Omaha, Nebraska. From the Section of Oncology-Hematology, Department of Internal Medicine, University of Nebraska Medical Center; the Department of Internal Medicine, Omaha Veterans Affairs Medical Center, Omaha, NE; and the Fred Hutchinson Cancer Research Center, Seattle, WA Division of Hematology/Oncology, University of Nebraska Medical Center, Omaha, NE University of Nebraska Medical Center UNMC, Internal Medicine Omaha NE USA Pier Paolo Piccaluga, Fabio Fuligni, Antonio De Leo, Clara Bertuzzi, Maura Rossi, Francesco Bacci, Elena Sabattini, Claudio Agostinelli, Anna Gazzola, Maria Antonella Laginestra, Claudia Mannu, Maria Rosaria Sapienza, Pier Luigi Zinzani, and Stefano A. Pileri, S. Orsola-Malpighi Hospital, University of Bologna, Bologna; Roberto Piva and Giorgio Inghirami, University of Torino, Torino; Monica Bellei and Massimo Federico, Università di Modena e Reggio Emilia, Modena, Italy; Sylvia Hartmann and Martin L.... From the Lymphoma Working Committee of the Autologous Blood and Marrow Transplant Registry, Health Policy Institute, Medical College of Wisconsin, Milwaukee, WI; University of Nebraska Medical Center, Omaha, NE; Ireland Cancer Center, University Hospitals of Cleveland, Case Western Reserve University, Cleveland, The Cleveland Clinic Foundation, Cleveland, and Miami Valley Hospital, Dayton, OH; University of Texas Health Science Center at San Antonio, San Antonio, TX; Fundaleu Hospital, Buenos Aires,... Human Genetics Laboratory Munroe‐Meyer Institute University of Nebraska Medical Center Omaha NE USA University of Nebraska Medical Center, Omaha, NE Laura A. Levit and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; Raymond P. Perez, Bristol-Myers Squibb, Lawrence Township, NJ; David C. Smith and Daniel F. Hayes, University of Michigan, Ann Arbor, MI; and Julie M. Vose, University of Nebraska Medical Center, Omaha, NE. From the Indiana University Medical Center; Eli Lilly and Company, Indianapolis, IN; University of Wisconsin Hospital & Clinics, Madison, WI; University of Nebraska Medical Center, Omaha, NE; UCLA School of Medicine, Los Angeles, CA; Case Western Reserve University/University Hospitals, Cleveland, OH; Minnesota Oncology Hematology, PA, Minneapolis, MN; Carle Clinic Associates, Urbana, IL; Joe Arrington Research & Cancer Center, Lubbock, TX; Cancer Center, Hackensack University Medical Center, Hackensack,... Julie M. Vose, University of Nebraska, Omaha, NE; Laura A. Levit, Patricia Hurley, and Suanna S. Bruinooge, American Society of Clinical Oncology, Alexandria, VA; Carrie Lee, University of North Carolina at Chapel Hill, Chapel Hill, NC; Michael A. Thompson, Aurora Health Care, Milwaukee, WI; Teresa Stewart, New Mexico Cancer Care Alliance, Albuquerque, NM; Janie Hofacker, Association of American Cancer Institutes, Pittsburgh, PA; and Daniel F. Hayes, University of Michigan, Ann Arbor, MI. Section of Hematology/Oncology, University of Nebraska Medical Center, Omaha, NB, USA. From the Department of Pediatrics, Section of Pediatric Bone Marrow Transplantation; Department of Internal Medicine, Section of Oncology/Hematology; and Department of Preventive and Societal Medicine, University of Nebraska Medical Center, Omaha, NE. From the James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester; Memorial-Sloan-Kettering Cancer Center; Weill Medical College of Cornell University, New York, NY; University of Michigan Cancer Center, Ann Arbor, MI; Johns Hopkins School of Medicine, Baltimore, MD; Stanford University Medical Center, Stanford, CA; University of Nebraska Medical Center, Omaha, NE; Corixa Corporation, Seattle, WA Lowell E. Schnipper, Beth Israel Deaconess Medical Center, Harvard Medical School; Therese Mulvey and Jeffrey Peppercorn, Massachusetts General Hospital; Deborah Schrag, Dana-Farber Cancer Institute, Boston, MA; Nancy E. Davidson, University of Pittsburgh Cancer Institute and University of Pittsburgh Medical Center Cancer Center, Pittsburgh; Adam P. Dicker, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA; Dana S. Wollins and Richard L. Schilsky, American Society of Clinical... Internal Medicine, Section of Hematology and Oncology, University of Nebraska Medical Center, Omaha, NE, USA From the Departments of Pathology and Microbiology; Biostatistics; and Internal Medicine, University of Nebraska Medical Center, Omaha, NE Section of Hematology/Oncology, University of Nebraska Medical Center, Nebraska Medical Center, Omaha 68198-7680, USA. jmvose@unmc.edu Division of Oncology/Hematology Department of Internal Medicine University of Nebraska Medical Center Omaha Nebraska Division of Hematology/Oncology University of Nebraska Medical Center Omaha NE USA Division of Oncology & Hematology University of Nebraska Medical Center Omaha NE USA Department of Internal Medicine, Division of Oncology & Hematology, University of Nebraska Medical Center, Omaha, NE 68198, USA; Department of Internal Medicine, Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE 68198, USA The Departments of Medicine, The University of Nebraska, Omaha, Nebraska, USA Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE From the Departments of Pathology and Laboratory Medicine, Medical Oncology, and Epidemiology, British Columbia Cancer Agency, University of British Columbia, Vancouver, BC, Canada; the University of Nebraska Medical Center, Omaha, NE; and the Department of Experimental Oncology, St Jude Children’s Research Hospital, Memphis, TN. From the Departments of Radiology, Internal Medicine, and Biostatistics, and the Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA; Department of Radiology, Mayo Clinic, Rochester, MN; Division of Nuclear Medicine, Ulm University Hospital, Ulm, Germany; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE; and Department of Internal Medicine, Georgetown University Hospital, Washington, DC Authors' Affiliations: 1Department of Genetics, Cell Biology and Anatomy; 2Eppley Institute for Research in Cancer and Allied Diseases; and 3Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska Division of Hematology and Oncology University of Nebraska Medical Center Omaha Nebraska Department of Internal Medicine, Division of Hematology–Oncology, University of Nebraska Medical Center, 987680 Nebraska Medical Center, Omaha, NE 68198, USA Xin Huang, Bin Meng, Wenfeng Cao, and Kai Fu, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Tianjin; Chengfeng Bi, West China Hospital, West China School of Medicine of Sichuan University, Chengdu, China; Xin Huang, Bin Meng, Javeed Iqbal, Anamarija M. Perry, Wenfeng Cao, Lynette M. Smith, Chengfeng Bi, Chunsun Jiang, Timothy C. Greiner, Dennis D. Weisenburger, James O. Armitage, Julie M. Vose, Timothy W. McKeithan, Wing C. Chan, and Kai Fu,... Fred & Pamela Buffett Cancer Center From the Department of Medicine, University of Nebraska Medical Center, Omaha, NE; Blood and Marrow Transplant Program, Oncology and Hematology Associates and Saint Lukes Hospital of Kansas City, Kansas City, MO; and the Department of Preventive & Societal Medicine, University of Nebraska Medical Center, Omaha, NE. University of Nebraska Medical Center Omaha Nebraska USA Massimo Federico, Monica Bellei, and Stefano Luminari, Università di Modena e Reggio Emilia, Modena; Stefano A. Pileri, Università di Bologna, Bologna, Italy; Thomas Rudiger, Stadisches Klinikum Karlsruhe, Karlsruhe, Germany; Bharat N. Nathwani, Ceders-Sinai Medical Center and University of Southern California Keck School of Medicine, Los Angeles, CA; Bertrand Coiffier, Hospices Civils de Lyon, Lyon; Nicholas Mounier, Hospital l'Archet, Nice, France; Nancy L. Harris, Massachusetts General Hospital and... University of Nebraska Medical Center, Omaha, Nebraska. Division of Oncology and Hematology; University of NebraskaMedical Center; Omaha NE USA Authors' Affiliations: Departments of 1Pathology and Microbiology and 2Hematology/Oncology and 3College of Public Health, Department of Biostatistics, University of Nebraska Medical Center, Omaha, Nebraska; 4Center for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, British Columbia, Canada; 5Metabolism Branch and 6Laboratory of Pathology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland; 7Department of Pathology, University of Arizona, Tucson, Arizona; 8Department of Pathology, University of Würzburg, Würzburg; 9Department of Clinical Pathology, Robert Bosch Hospital and Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Baden-Württemberg, Germany; 10Department of Pathology, The Norwegian Radium Hospital, University of Oslo, Oslo, Norway; 11Hospital Clinic, University of Barcelona, Barcelona, Spain; 12Clinical Pathology, Oregon Health, Oregon; and 13Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio From the Departments of Pathology and Microbiology, Internal Medicine, and Preventive and Societal Medicine, University of Nebraska Medical Center, Omaha, NE. From the University of Alabama at Birmingham Comprehensive Cancer Center; Stanford University Medical Center, Palo Alto, CA; University of Nebraska Medical Center, Omaha; Virginia Mason Medical Center, Seattle WA; and NeoRx Corporation, Seattle, WA. From the University of Nebraska Medical CenterOmaha, NE; University of Michigan Medical Center, Ann Arbor, MI; University of Alabama-Birmingham, Birmingham, AL; St Bartholomew’s Hospital, London; Christie Hospital National Health Service Trust, Manchester, England; Stanford University Medical Center, Palo Alto; Coulter Pharmaceutical, South San Francisco, CA; and Memorial Sloan-Kettering Cancer Center, New York, NY. From the James P. Wilmot Cancer Center, University of Rochester, Rochester; The Leukemia & Lymphoma Society, White Plains; Lymphoma Service, Memorial Sloan-Kettering Cancer Center, New York, NY; Genentech Inc, South San Francisco, CA; Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN; Emory University, Atlanta, GA; Medical Oncology, Simon Cancer Center, Morristown, NJ; University of Wisconsin Paul P. Carbone Comprehensive Cancer Center, Madison, WI; Medical Oncology, Sarah Cannon... From the Epidemiology of Platelet Recovery Study Group and Genentech, South San Francisco, CA. University of Nebraska Medical Center Division of Hematology/Oncology, University of Nebraska Medical Center, Omaha, Nebraska. Division of Hematology/Oncology, University of Nebraska Medical Center, Omaha, Nebraska, USA. University of Nebraska Medical Center Omaha Nebraska 3University of Nebraska Medical Center, Omaha, Nebraska. Division of Hematology/Oncology, The Nebraska Medical Center, Omaha, Nebraska. |
Incoming Links
Total number of triples: 400.